ADAPTIVE-DESIGN DOSE FINDING STUDY TO ASSESS THE ANTIVIRAL EFFICACY AND SAFETY OF NIM811 ADMINISTERED IN COMBINATION WITH STANDARD OF CARE (SOC) IN RELAPSED HEPATITIS C VIRUS 1 (HCV-1) INFECTED PATIENTS: